Because CD22 is upregulated on B-cell lymphomas, this higher level of expression allows the T cells with the TCR recognising the membrane-distal epitope on CD22 to lyse lymphoma cells, while sparing normal B cells 8. The gene discussed is CD22; the disease is B-cell non-Hodgkin lymphoma.